Shrey Sukhadia

Dartmouth–Hitchcock Medical Center

Papers

1

Total Citations

23

H-Index

1

About

Dr. Shrey Sukhadia is a leading figure in the clinical implementation of next-generation sequencing (NGS) for precision oncology. His primary research focuses on developing and validating scalable, somatic-only tumor exome workflows designed to democratize access to genomic testing across diverse institutional settings. His most-cited work, "Validation and Implementation of a Somatic-Only Tumor Exome for Routine Clinical Application" (2024, 23 citations), directly addresses the critical challenge of standardizing NGS protocols for global use, offering a robust framework that balances resource constraints with clinical accuracy. This contribution is pivotal for enabling routine genomic profiling in both well-resourced and limited-resource environments, bridging a significant gap in translational cancer genomics. Dr. Sukhadia’s work is notable for its practical emphasis on validation and implementation, ensuring that complex genomic technologies can be reliably integrated into everyday clinical workflows. His research is instrumental in moving precision medicine from specialized centers to broader clinical adoption, making a tangible impact on how tumor genomic data is generated and interpreted for patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
23
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
Validation and Implementation of a Somatic-Only Tumor Exome for Routine Clinical Application
23 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Dartmouth–Hitchcock Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago